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INflAmmAtIoN is believed to contribute to the onset of many age-related diseases as evidenced by a variety of 
medical studies linking proinflammatory cytokines to Al-
zheimer’s disease (1), Parkinson’s disease (2), amyotrophic 
lateral sclerosis (3), and multiple sclerosis (4). much atten-
tion has been paid to interleukin (Il)-6 because of its asso-
ciation with cardiovascular disease, the leading cause of 
death. Il-6 is associated with a broad spectrum of age-re-
lated illnesses, chronic stress, and functional disability in 
older adults (5,6). Il-6 is also a strong inducer of C-reactive 
protein (CRP) by the liver, and both Il-6 and CRP are im-
portant in the development of cardiovascular disease (7,8). 
Il-6 and CRP also play a pathogenic role in a number of 
diseases associated with disability in older adults, such as 
arthritis, osteoporosis, and depression among others (9).
Studies of older humans have reported age-related in-
creases in proinflammatory cytokines, but the switch from 
the inflammatory burst that resolves following an infection or 
injury to the chronic elevation encountered in many older 
adults is not well understood (10). Several investigations have 
indicated that there is an age-related increase in circulating 
Il-6 (11–14), which has been called a “cytokine for geron-
tologists” (15). However, some studies have found no changes 
with age (16,17). Similarly, tumor necrosis factor (tNf)-a, a 
cytokine that is involved in septic shock, was reportedly in-
creased in some studies (11,18) but not others (17,19).
Anti-inflammatory mediators, such as Il-10 and interleu-
kin-1 receptor antagonist (Il-1ra), may also be important in 
the aging process because they counteract proinflammatory 
cytokines. With regards to Il-10, few studies have measured 
circulating levels of this cytokine, but there have been re-
ports that indicated no change occurs with aging (17,20). 
Reports have also shown an age-related increase in the 
Il-1ra (21,22). Altogether, the discrepancies regarding 
these cytokines mostly likely relate to variations in age and 
sample size.
Besides age, cytokine levels may also be influenced by 
ethnicity. Plasma levels of Il-8 and granulocyte colony-
stimulating factor were elevated in African Americans com-
pared with Caucasians (23), and tNf-a has been reported 
to be higher in nonobese mexican Americans compared 
with non-Hispanic whites (24). Because there is little other 
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information on circulating proinflammatory cytokine levels 
and ethnicity, our goal was to investigate plasma levels of 
circulating cytokines in relation to ethnicity as well as age 
in a large population-based study. We found age-related dif-
ferences in proinflammatory cytokines as well as significant 
differences in circulating cytokine levels between mexican 
Americans, non-Hispanic whites, and non-Hispanic blacks.
Materials and Methods
Participants
Respondents for this study come from the texas City 
Stress and Health Study, an ongoing assessment of risk, 
coping, stress, and health in a tri-ethnic community living in 
texas City, texas. this study set out to explore sociobio-
logical patterns with a focus on Hispanics (25). the sample 
was generated through a census of Hispanic households and 
a simple random sample of non-Hispanic households. We 
first selected three ethnic strata: mexican Americans aged 
25–64 years, mexican Americans aged 65 years and older, 
and non-Hispanics. We next selected housing units (HUs) in 
each stratum, including all Hispanic HUs and one in eight 
non-Hispanic HUs. finally, we randomly selected one adult 
per household among mexican Americans aged 25–64 years 
and among non-Hispanics and all mexican Americans aged 
65 years and older. listing, enumeration, and interviewing 
followed standard U.S. Census Bureau Current Population 
Survey methods with appropriate local modifications. Inter-
view rates in the main study were 80%, yielding a sample 
size of 2,706. there were 102 respondents who did not self-
identify as white, black, or of being of mexican descent and 
were removed from the analyses. thus, the final sample size 
was 2,604. Blood samples were received from 54% of the 
participants (n = 1,411).
Blood samples were drawn from participants between 8 
and 11 am. to measure biomarkers, blood was drawn into 
EDtA tubes. Plasma was obtained after centrifugation and 
stored in 1-ml aliquots at −70°C until testing. the institu-
tional review board at the University of texas medical 
Branch approved the study protocol, and informed consent 
was obtained from all participants.
Measurement of Plasma Cytokines
Cytokines were assayed in batched samples using ElISA 
or enzyme immunoassay (EIA) assays. CRP (high sensitivity) 
was measured using commercially available kits according to 
the manufacturer’s instructions (Diagnostic Systems labora-
tories, Webster, tX).
for measurement of Il-6, Il-1ra, Il-10, and tumor ne-
crosis factor-receptor 1 (tNf-r1), optEIA assay kits were 
purchased from BD Pharmingen (San Diego, CA) or R&D 
Systems (minneapolis, mN). In general, the protocol for the 
analysis of each cytokine was similar. for each cytokine, 
all patient samples from each study period were analyzed 
simultaneously with an identical set of control samples. 
Briefly, all patient serum samples and reagents were brought 
to room temperature. first, standards were prepared from a 
stock solution. the appropriate dilutions were made to es-
tablish a standard curve. fifty microliters of ElISA diluent 
was pipetted into each well of the 96-well plates. then, 100 
ml of the standards and samples (all done in duplicate) was 
pipetted into wells and mixed with the diluent. the plate 
was shaken gently and covered with a plate sealer, and the 
samples were incubated for 2 hours at room temperature. 
After incubation, the standards and samples were aspirated 
from the wells and washed with buffer using an Embla 
96/384-well microplate washer (molecular Devices, 
menlo Park, CA). one hundred microliters of detection 
antibody (conjugated to avidin–horseradish peroxidase) 
was added. this was incubated for 1 hour at room tempera-
ture. the wells then were washed with buffer and 100 ml of 
3,3′,5 5′-tetramethylbenzidine subsequently was added. the 
plate then was incubated in the dark at room temperature for 
20–30 minutes. Afterward, 50 ml of sulfuric acid (2N) was 
added. Absorbance was read at 450 nm using a Spectramax 
Plus plated reader (molecular Devices). Results initially 
were calculated by optical density and converted to pico-
grams per milliliter by log–log computation with applica-
tion according to the standard curve.
Statistics
Analysis of variance (ANoVA) was conducted to deter-
mine differences by age and ethnicity in cytokine levels. Age 
was divided into seven age groups: 25–29, 30–39, 40–49, 
50–59, 60–69, 70–79, and 80 years and older (age range of 
sample 25–91). Ethnic groups included non-Hispanic white, 
non-Hispanic black, foreign-born mexican American, and 
US-born mexican American. In addition, we tested whether 
or not the relationships between age and cytokine levels 
were linear. All analyses were performed using SAS 9.2.
Results
Blood samples were received from 54% of participants 
(n = 1,411); the remainder of the participants declined to 
participate in the blood sampling. Compared with the entire 
study cohort, those providing blood samples were a higher 
percentage of females (p < .03), a lower percentage of non-
Hispanic blacks (p < .01), lower mean perceived physical 
health (p < .001), and higher mean levels of chronic condi-
tions (p < .01). the demographic data and cytokine levels 
for all respondents are shown in table 1.
the unadjusted mean cytokine levels, grouped by decade 
of age, are shown in table 2. No significant differences in 
Il-1ra, Il-10, or CRP were found. two statistical tests were 
performed for each cytokine. An ANoVA assessed whether 
there were any significant differences in cytokine levels 
among the age categories, whereas a test for linear trend 
assessed whether cytokine values increased or decreased 
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significantly with increasing age. for Il-1ra, Il-10, and 
CRP, there were no significant differences in levels among 
the age categories. for both Il-6 and tNf-r1, there were 
significant increases in levels with increasing age.
Age-related changes in Il-6 and tNf-r1 by decade (age 
range 25–91) are shown in figure 1. Between the ages of 25 
and 49, there was little or no increase in tNf-r1 and Il-6. 
thereafter, tNf-r1 increased with each decade. Il-6 also 
increased after age 50, but the rate was less than that of 
tNf-r1. Among the entire sample, there was a significant 
correlation between age and tNf-r1 (r = .331; p < .001) as 
well as age and Il-6 (r = .129; p < .001).
Cytokine levels were then grouped according to ethnicity 
(table 3). We first divided the groups into non-Hispanic 
white (n = 535), non-Hispanic black (n = 150), and mexican 
Americans (n = 726). the mexican American category was 
subdivided into foreign-born (n = 181) and US-born His-
panics (n = 545). Non-Hispanic whites had significantly 
higher Il-1ra levels than either foreign-born or US-born 
mexican Americans. the lowest levels of Il-1ra were ob-
served for foreign-born Hispanics. Blacks had significantly 
higher levels of circulating Il-6 than non-Hispanic whites. 
the lowest levels of Il-6 were found in foreign-born His-
panics. CRP levels were significantly higher in blacks com-
table 1. Demographic and Cytokine levels  
(in picograms per milliliter) for Respondents in the texas City Stress 
and Health Study (n = 1,411)




 Non-Hispanic black 10.63
 Non-Hispanic white 37.92
Cytokines
 Il-1ra 164.40 (383.05)
 Il6 1.95 (4.72)
 Il-10 4.88 (15.90)
 tNf-r1 1824.43 (1471.55)
 CRP (mg/dl) 13.58 (16.51)
Note: CRP = C-reactive protein; Il = interleukin; Il-1ra = interleukin-1 
receptor antagonist; tNf-r1 = tumor necrosis factor-receptor 1.
table 2. Unadjusted mean Cytokine levels (in picograms per milliliter) by Age Group for Respondents in the texas City Stress and Health 
Study (n = 1,411)
Age Group (y) n Il-1ra Il-6 Il-10 tNf-r1 CRP (mg/dl)
25–29 103 182 ± 38 1.4 ± 0.5 4.6 ± 1.6 1461 ± 140 12.4 ± 1.6
30–39 262 122 ± 24 1.7 ± 0.3 5.0 ± 1.0 1529 ± 88 14.2 ± 1.0
40–49 289 180 ± 23 1.5 ± 0.3 6.7 ± 0.9 1466 ± 84 12.4 ± 1.0
50–59 269 213 ± 24 2.1 ± 0.3 4.3 ± 1.0 1819 ± 87 14.3 ± 1.0
60–69 234 145 ± 25 1.8 ± 0.3 3.9 ± 1.0 1947 ± 93 14.0 ± 1.1
70–79 193 184 ± 28 2.8 ± 0.3 4.0 ± 1.1 2494 ± 103 13.1 ± 1.2
80+ 61 95 ± 49 3.3 ± 0.6 5.9 ± 2.0 2946 ± 182 15.7 ± 2.1
p Value for ANoVA .084 .025 .433 <.001 .624
p Value for linear age trend .391 .002 .911 <.001 .306
Note: All data are expressed as means ± SE. ANoVA = analysis of variance; CRP = C-reactive protein; Il = interleukin; Il-1ra = interleukin-1 receptor antagonist; 
tNf-r1 = tumor necrosis factor-receptor 1.
pared with non-Hispanic whites or mexican Americans 
(both foreign born and US born). the lowest levels of CRP 
were found in foreign-born Hispanics. No significant differ-
ences were found in Il-10 or tNf-r1 levels when compar-
ing ethnic groups. After adjusting for body mass index 
(BmI), CRP levels were no longer significant higher in non-
Hispanic blacks. In addition, non-Hispanic whites had sig-
nificantly greater levels of tNf-r1 (p < .05) than either 
non-Hispanic blacks or Hispanics.
Discussion
Inflammatory cytokines represent important links be-
tween aging and associated diseases. Several prior studies 
have shown age-related increases in inflammatory cytokine 
levels, and our results are in agreement with these studies. 
the cytokine with the strongest association with age was 
tNf-r1. We analyzed tNf-r1 instead of tNf-a for two rea-
sons: (a) it is detectible when tNf-a is not and (b) tNf-a 
has a short half-life (~15 minutes); as such, tNf-r1 has 
been proposed as a surrogate marker for tNf-a (26). Im-
portantly, tNf-a has been implicated in obesity, diabetes, 
and the insulin resistance syndrome. tNf-a is also strongly 
associated with mortality in older adults (27) as well as with 
Alzheimer’s disease and atherosclerosis (11,28).
Consistent with prior studies (11–14), Il-6 increased 
with age. our data, which includes a large population of 
adults over a wide ranges of ages, support prior studies 
demonstrating age-related increases in these proinflamma-
tory markers (29,30). Notably, the age group older than 80 
years had the highest levels of both Il-6 and CRP. this is 
important because increased levels of Il-6 and CRP are as-
sociated with atherosclerosis (31), coronary heart disease 
(32,33), congestive heart failure (34), and arthritis (5), well-
known diseases that affect older adults. overall, our results 
are in agreement with the belief that immunosenscence is 
associated with chronic low-grade inflammation.
We also measured the anti-inflammatory mediators Il-10 
and Il-1ra in this study. Plasma concentrations of Il-10 were 
not increased with age. these results are in agreement with 
prior studies (17,20) that showed no changes in circulating 
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Il-10. our study, which included a larger number of partici-
pants (n = 1,411) across a wide range of ages, confirms these 
findings. In contrast to prior studies (21,22), we found no 
changes in plasma concentrations of Il-1ra. However, fer-
rucci and coworkers (30) found no correlation between age 
and Il-1ra after adjusting for cardiovascular risk factors. the 
lack of changes in these anti-inflammatory markers may 
have important health consequences given the increased lev-
els of tNf-r1 and Il-6 as this may be reflective of an imbal-
ance in the cytokine network in the elderly participants. 
Interestingly, the lowest levels of Il-1ra were found in the 
oldest group (aged 80 years and older). As Il-1 is inhibited 
by circulating Il-1ra, it is tempting to speculate that lower 
Il-1ra levels reflect reduced production of Il-1. this would 
correlate with the lack of fever in the elderly participants, 
which is often absent or blunted (35). It has been reported 
that high levels of plasma Il-1ra, along with Il-6 and CRP, 
were predictive of higher mortality (36). therefore, success-
ful aging may be associated with lower levels of Il-1ra. fur-
ther studies are needed to determine the relationships between 
Il-1ra, Il-1, and their role in healthy aging.
Because our study population was tri-ethnic in nature, we 
analyzed the data accordingly and found significant associ-
ations between cytokine levels and ethnicity. the highest 
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figure 1. Plasma levels of tumor necrosis factor-receptor 1 (tNf-r1) and 
interleukin (Il)-6 (mean ± SE) by age (n = 1,411).
table 3. Age-Adjusted mean Cytokine levels (in picograms per milliliter) by Ethnicity for Respondents in the texas City Stress and Health 
Study (n = 1,411)
Ethnicity n Il-1ra Il-6 Il-10 tNf-r1 CRP (mg/dl)
Non-Hispanic white 535 208 ± 17*,† 1.7 ± 0.2 5.3 ± 0.7 1917 ± 62 13.4 ± 0.7
Non-Hispanic black 150 148 ± 32 2.7 ± 0.4‡ 4.3 ± 1.3 1668 ± 117 17.2 ± 1.3*,†,‡
Hispanic 726
foreign born 181 119 ± 29 1.8 ± 0.4 4.5 ± 1.2 1756 ± 108 12.3 ± 1.2
US born 545 147 ±17 2.1 ± 0.2 4.8 ± 0.7 1811 ± 61 13.2 ± 0.7
Notes: All data are expressed as means ± SE. CRP = C-reactive protein; Il = interleukin; Il-1ra = interleukin-1 receptor antagonist; tNf-r1 = tumor necrosis 
factor-receptor 1.
* Significantly (p < .05) higher than US-born Hispanics.
† Significantly (p < .05) higher than foreign-born Hispanics.
‡ Significantly (p < .05) higher than whites.
non-Hispanic whites or blacks. Interestingly, it has been 
proposed that the health status of Hispanics in the South-
western United States is comparable more so with whites 
than with blacks despite the fact that socioeconomically 
Hispanics are more similar to blacks than the more advan-
taged whites; this has been aptly named the “Hispanic Para-
dox” (37). our results support this concept, which 
demonstrates that, collectively, lower levels of inflamma-
tory cytokines were found in Hispanics compared with 
whites or blacks. Notably, the lowest inflammatory levels 
were found in foreign-born Hispanics. We have previously 
proposed that protective measures (eg, acculturation) may 
in part underlie the differences between foreign-born and 
US-born Hispanics because we found that increasing years 
in the United States was associated with increasing Il-1ra 
levels among Hispanic women at 22–24 weeks of pregnancy 
(38). further research is needed to determine the mecha-
nisms underlying the differences in cytokine profiles be-
tween foreign-born and US-born Hispanics.
one potential explanation for the ethnic variations in cy-
tokine levels is differences in cytokine gene polymorphisms. 
Allelic variations in the regulatory regions of inflammatory 
cytokine genes have been shown to affect the expression of 
some cytokines. Several studies have focused on Il-6 be-
cause of its biological importance and have demonstrated 
that the G/G Il-6 genotype, which results in high Il-6 pro-
duction, is predominantly found in blacks (39,40). It has 
been hypothesized that the dissimilarities in cytokine gene 
polymorphisms may contribute to the differences in inflam-
matory responses and cancer incidence and mortality in 
blacks (41). Additionally, obesity was a significant determi-
nant of CRP levels in non-Hispanic blacks, and BmI was 
significantly higher in non-Hispanic blacks than either non-
Hispanic whites or Hispanics (data not shown).
In summary, our results confirm and extend other studies 
demonstrating age-related increases in circulating proinflam-
matory cytokines. In addition, we have shown ethnic differ-
ences in cytokine levels, and to our knowledge, this is the first 
study demonstrating ethnic differences in proinflammatory 
and anti-inflammatory cytokine profiles in large population-
based study. future studies are needed to determine the 
epigenetic link between inflammation and ethnicity.
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